Shed provides access to Wegovy through a fully online, provider-led care model
The SURPASS clinical trials involving over 10,000 patients did not identify palpitations as a significant safety signal, with gastrointestinal effects being the most frequently reported adverse reactions
The "Glow" blend is being researched for its potential involvement in biological processes related to inflammation modulation, tissue repair mechanisms, angiogenesis (blood vessel formation), extracellular matrix regulation, and cellular cytoprotection
The healing process of any connective tissue consists of three consecutive stages: inflammation, regeneration, and remodeling
All vials are sealed, lab-grade, and handled in accordance with proper cold-chain storage protocols during fulfillment